The Surveillance Gap: Why Aortic Stenosis Monitoring is Falling Short

In the management of Aortic Stenosis (AS), we often focus on the "when" and "how" of intervention. However, new research highlights a more fundamental challenge: the "if" of consistent monitoring. A recent large-scale study published in Circulation: Population Health and Outcomes reveals a significant gap between clinical guidelines and real-world echocardiographic surveillance.

The data, which followed over 20,000 patients, suggests that many of our highest-risk patients are not receiving recommended follow-up scans, directly impacting survival rates and the timing of Aortic Valve Replacement (AVR).

The Surveillance Paradox

The study found a counterintuitive trend: as the severity of the disease increases, adherence to monitoring guidelines actually decreases.

 * Severe AS: Only 49% of patients received an echo within the recommended 6–12 month window.

 * Mild AS: Conversely, 74% of patients were monitored according to the 3–5 year guideline.

 * The Survival Link: Patients who remained guideline-concordant had significantly lower mortality rates (28.8%) compared to those who were not (42.2%).

Identifying Barriers to Care

Why are high-risk patients falling through the cracks? Several "real-world" factors contribute to this oversight:

 * Symptom Masking: Because AS is often asymptomatic until a critical stage, patients may not feel the urgency of a "routine" scan.

 * Fragmented Follow-up: As patients age, care often transitions between multiple providers, leading to missed reminders.

 * The Specialist Factor: Patients managed by a cardiologist were much more likely to stay updated on their surveillance than those managed solely by primary care.

Future Solutions: AI and System Alerts

To bridge this gap, the medical community is looking toward AI-driven solutions. Natural language processing (NLP) can be used to interpret echo reports and trigger automated provider alerts when a patient is due for follow-up. Programs like the AHA’s Target: Aortic Stenosis are also working to standardize care from diagnosis to intervention.

Clinical Perspective

For providers, the takeaway is clear: active surveillance is a mortality-reducing intervention. For patients, a "routine" echo is the most vital tool we have to ensure we intervene at the "sweet spot" of disease progression.

The Bottom Line: We must move toward a proactive, system-level approach to ensure no patient with Aortic Stenosis is "lost to follow-up."

Reference

Fitzpatrick JK, Go AS, Bauer M, et al. Association of guideline-concordant echocardiographic surveillance with mortality and aortic valve replacement in US adults with aortic stenosis. Circ Popul Health Outcomes. 2026;19:e012822.